Alzheimer’s Disease Therapeutics and Diagnostics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Alzheimer’s Disease Therapeutics and Diagnostics Market is expected to progress at a CAGR of 7% during the forecast period 2022-2028.

Alzheimer’s disease (AD) is the most common cause of progressive dementia in the elderly population. The number of Alzheimer’s disease cases worldwide has increased exponentially, highlighting the need to develop effective treatments. According to the Alzheimer’s Association, in 2016, approximately 5.4 million Americans of all ages had Alzheimer’s disease. 1 in 9 people over the age of 65 has Alzheimer’s. By 2050, the number of people over the age of 65 with Alzheimer’s disease is projected to nearly triple, from 5.2 million to 13.8 million, excluding medical advances to prevent or treat the disease. The mortality rate from Alzheimer’s disease is quite high. Between 2000 and 2013, deaths from heart disease, stroke, and prostate cancer decreased by 14%, 23%, and 11%, respectively, in the United States, while deaths from AD increased by 71%.

Market Segments

By Type:

• Biomarkers
• Cholinesterase inhibitors
• NMDA receptor antagonists
• Brain imaging
• Blood tests

By Application:

• Drugs Market
• Diagnostics Market

Key Players

The key manufacturers operating in the market are Abbvie Inc., AC Immune SA, Allergan PLC, Amarantus Bioscience Holdings, Anavex LifeSciences, Avid Radiopharmaceuticals, Axon Neuroscience, Axovant Sciences, Daiichi Sankyo Co, Eli Lilly, F. Hoffmann La Roche AG, GE Healthcare, Janssen Pharmaceuticals etc.

Scope of the Report

The research study analyzes the global Alzheimer’s Disease Therapeutics and Diagnostics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Alzheimer’s Disease Therapeutics and Diagnostics Market Report

1. What was the Alzheimer’s Disease Therapeutics and Diagnostics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Alzheimer’s Disease Therapeutics and Diagnostics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Alzheimer’s Disease Therapeutics and Diagnostics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.